Cargando…

Eligibility for subcutaneous implantable cardioverter-defibrillator in patients with left ventricular assist device

PURPOSE: The subcutaneous implantable cardioverter-defibrillator (S-ICD) could be a promising alternative to the conventional transvenous ICD in patients with LVAD due to its reduced risk of infection. However, surface ECG is altered following LVAD implantation and, since S-ICD detection is based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zormpas, Christos, Eiringhaus, Jörg, Hillmann, Henrike A. K., Hohmann, Stephan, Müller-Leisse, Johanna, Schmitto, Jan D., Veltmann, Christian, Duncker, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925469/ https://www.ncbi.nlm.nih.gov/pubmed/32613315 http://dx.doi.org/10.1007/s10840-020-00810-1

Ejemplares similares

Changes in eligibility for a subcutaneous cardioverter-defibrillator after implantation of a left ventricular assist device–A prospective analysis
por: Zormpas, Christos, et al.
Publicado: (2023)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Premature end of service of implantable cardioverter-defibrillator by magnetic interference with left-ventricular assist device
por: Eiringhaus, Jörg, et al.
Publicado: (2021)

Extended follow‐up after wearable cardioverter‐defibrillator period: the PROLONG‐II study
por: Mueller‐Leisse, Johanna, et al.
Publicado: (2021)

Feasibility and First Results of Heart Failure Monitoring Using the Wearable Cardioverter–Defibrillator in Newly Diagnosed Heart Failure with Reduced Ejection Fraction
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2021)

Delayed Improvement of Left Ventricular Function in Newly Diagnosed Heart Failure Depends on Etiology—A PROLONG-II Substudy
por: Mueller-Leisse, Johanna, et al.
Publicado: (2022)

Author reply: S‐ICD eligibilities in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Similarly high success and low complication rates of catheter ablation for idiopathic premature ventricular contractions from the left and right ventricular outflow tract
por: Mueller-Leisse, J, et al.
Publicado: (2023)

Prediction of ablation success of idiopathic premature ventricular contractions with an inferior axis using the twelve-lead electrocardiogram
por: Mueller-Leisse, J, et al.
Publicado: (2023)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Acute echocardiographic and electrocardiographic effects of triggered left ventricular pacing
por: Pfeffer, Tobias Jonathan, et al.
Publicado: (2022)

Selection of patients eligible for implantable cardioverter defibrillator: beyond left ventricular ejection fraction
por: Rizzello, Vittoria
Publicado: (2022)

Cardiac Rhythm Monitoring Using Wearables for Clinical Guidance before and after Catheter Ablation
por: Hillmann, Henrike Aenne Katrin, et al.
Publicado: (2022)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

De novo subcutaneous implantable cardioverter-defibrillator in patient with left ventricular assist device
por: Reichert, William, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter‐defibrillator noise following left ventricular assist device implantation
por: Khetarpal, Banveet Kaur, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Subcutaneous implantable cardioverter defibrillators in patients with left ventricular assist devices: case report and comprehensive review
por: López-Gil, María, et al.
Publicado: (2019)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator: Early Experience
por: Souza, Fernando Sérgio Oliva, et al.
Publicado: (2017)

Comparative outcomes of subcutaneous and transvenous cardioverter-defibrillators
por: Liang, Jin-Jun, et al.
Publicado: (2019)

Subcutaneous Implantable Cardioverter-Defibrillator Lead Dislodgement Masquerading as Left Shoulder Pain
por: Chirumamilla, Yashitha, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Ventricular tachycardia detection with the subcutaneous implantable cardioverter-defibrillator: Tracing the cause of an absent tracing
por: Mansour, Fadi, et al.
Publicado: (2019)

The subcutaneous implantable cardioverter defibrillator––review of the recent data
por: Westerman, Stacy B, et al.
Publicado: (2018)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Painful detour of subcutaneous implantable cardioverter-defibrillator lead
por: Bisson, Jasmine, et al.
Publicado: (2022)

Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview
por: Guarracini, Fabrizio, et al.
Publicado: (2023)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective
por: Nesti, Martina, et al.
Publicado: (2023)

Role of the Wearable Defibrillator in Newly Diagnosed Heart Failure
por: Duncker, David, et al.
Publicado: (2018)

Defibrillators for prevention from sudden cardiac death: is it that easy?
por: Duncker, David, et al.
Publicado: (2020)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016)

Successful defibrillation verification in subcutaneous implantable cardioverter‐defibrillator recipients by low‐energy shocks
por: Biffi, Mauro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jj4nk37h0gpshvj18l03u399an